Recognition and Validation of Druggable Targets from the Response to Cognitive Behaviour Therapy in Myotonic Dystrophy type 1 patients from Integrated -Omics Networks

来自 Integrated-Omics Networks 的强直性肌营养不良 1 型患者对认知行为治疗反应的可药物靶标的识别和验证

• 批准号: 387442
• 负责人: Mackenzie Alexander E
• 金额: $ 5.46万
• 依托单位: University of Ottawa
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-06-01 至 2021-06-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=387442&lang=en
• 关键词: Cognitive Behavioural Therapy (Cbt); Myotonic Dystrophy Type 1 (Dm1); Systems Biology

Myotonic dystrophy type 1 (DM1) is the most common adult form of muscular dystrophy affects virtually all tissues; the untreatable condition causes significant illness and death impacting patient and family quality of life and socio-economic status. Lim

强直性肌营养不良1型（DM 1）是最常见的成人形式的肌营养不良症，几乎影响所有组织;无法治疗的疾病会导致严重的疾病和死亡，影响患者和家庭的生活质量和社会经济地位。 Lim